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1005-63 Initial Clinical Experience With an Intravascular 
Ultrasound-Guided Transmembrane Puncture Device to 
Facilitate Recanalization of Total Femoral Artery 
Occlusions
Dierk Scheinert, Andrej Schmidt, Susanne Scheinert, Sven Bräunlich, Giancarlo 
Biamino, Clinical and Interventional Angiology, Heart Center, Leipzig, Germany
Purpose: Failure to recanalize chronic superficial femoral artery occlusions is caused in
the majority of the cases by subintimal passage of the occlusion with inability to re-enter
the true lumen with the guide-wire. The present study details our initial experience with
the CrossPoint TransAccess crossing device (Transvascular Inc.) to facilitate recanaliza-
tion of total femoral artery occlusions.
Methods: 14 consecutive patients (11 male, mean age 63 years) who failed recanaliza-
tion attempts of chronic superficial femoral artery occlusions (mean occlusion length 12.7
cm) with standard techniques were re-scheduled for a secondary recanalization proce-
dure. The CrossPoint device is a 6.2F rapid exchange catheter, which tracks over an
0.014"-wire. A 20MHz phased array IVUS transducer is integrated into the tip of the cath-
eter allowing visualization of the vessel morphology. Using the guidance of the IVUS
crossectional image supported by colour-flow imaging the true lumen is punctured with
an integrated 24G needle allowing delivery of a second 0.014"-wire.
Results: Re-entry into the true lumen was successfully accomplished in all cases without
complications. In 4 cases with severe calcification predilatation of the false channel was
necessary to allow advancement of the CrossPoint device. Furthermore, in patients with
severe calcification multiple puncture attempts were necessary to penetrate the dissec-
tion membrane. A procedural success (<25% residual stenosis) could be achieved in all
cases after predilatation and stenting of the occlusion with selfexpanding nitinol stents.
Conclusion: The CrossPoint device is an effective and save tool to facilitate true lumen
re-entry during recanalization of total superficial femoral artery occlusions.
1005-64 Patent Foramen Ovale Closure Using a Blind Transeptal 
Technique Is Safe
Georges A. Feghali, Jamshid Alaeddini, Tyrone J. Collins, Stephen R. Ramee, 
Christopher J. White, James Stephen Jenkins, Ochsner Clinic Foundation, New Orleans, 
LA
Background: Percutaneous closure of patent foramen ovale (PFO) is an alternative to
surgical treatment of this defect. Transesophageal echocardiography (TEE) or intracar-
diac echocardiography (ICE) guidance is used for percutaneous placement of closure
devices. The use of general anesthesia during TEE or the use of ICE significantly
increases the cost of this procedure. We report our experience of PFO closure with Car-
dioSEAL using transeptal puncture without TEE or ICE guidance.
Methods: We report 29 consecutive patients (men 18, age 52±13, ejection fraction
60±3%) with cerebral embolic event and associated PFO treated with percutaneous Car-
dioSEAL placement using the transeptal approach. Previous data from 33 consecutive
patients using TEE or ICE guidance for PFO closure was used as a control group. The
CardioSEAL device was used in all patients. Procedural success was defined as suc-
cessful placement of the device. Follow-up transthoracic echocardiography (TTE) with
bubble study at 3 month was performed in all but one patient.
Results: Twenty-eight patients in the transeptal group presented with a cerebral embolic
event and 3 patients experienced extracranial embolic events. The CardioSEAL device
was successfully deployed in all 29 patients. There was no in-hospital mortality or throm-
boembolic event. All patients were discharged within 24 hours of the procedure. The
average device size was 29±2 mm. There was no significant difference between the
study group and the control in fluoroscopy time (9±5 vs 9.4±5 min, p=NS) and amount of
contrast used (136±60 vs 139±68 ml, p=NS). At a mean follow up of 69±58 days one
patient had atrial fibrillation, device associated thrombus, and a transient ischemic neuro-
logical event. Another patient committed suicide prior to follow-up. Four patients had int-
racardiac shunt detected by TTE with bubble contrast.
Conclusion: PFO closure using a blind transeptal technique without use of general anes-
thesia, TEE, or ICE guidance is a safe procedure without additional risks and cost. A
large randomized trial and longer follow-up is needed to determine if a blind transeptal
technique is comparable to echo guided techniques.
1005-65 Percutaneous Left Atrial Appendage Transcatheter 
Occlusion (PLAATO™) to Prevent Stroke in Patients 
With Atrial Fibrillation: Interim Results of the 
Multicenter Feasibility Trial
Yves L. Bayard, Franziska Buscheck, Stefan Ostermayer, Mark Reisman, Michael D. 
Lesh, Toshiko Nakai, William Gray, Heyder Omran, Paul Kramer, Antonio Bartorelli, Paolo 
Della Bella, Peter Block, Carlo DiMario, Ray Matthews, Jeffrey Moses, Athena Poppas, 
David Williams, Allan Skanes, Bernhard Meier, Paul Teirstein, Kai Billinger, Thomas 
Trepels, Dirk Fleschenberg, Horst Sievert, CardioVascular Center, Frankfurt, Germany
Background: In order to prevent stroke in patients with AF and additional risk factors
who are suboptimal candidates for warfarine therapy, 103 persons have been enrolled in
the PLAATO™ Multicenter Trial so far (average age=71 yrs, 43-90 yrs; M/ F= 63/ 40).
Transcatheter occlusion prooved to be a safe procedure, nonetheless its benefit is still to
be discussed.
Methods: The risk of stroke for every patient enrolled in the PLAATO™ Multicenter Trial
was calculated according to the CHAD2 Risk Classification Scheme. Besides AF, this
scheme considers other stroke risk factors such as congestive heart failure, hypertension
(systolic >160 mm Hg), age greater than 75 years, diabetes and prior cerebral ischemia.
Results: Follow up tests have been performed in 101 patients that were enrolled in the
study (68,26 patient years). Most of the patients having several additional risk factors
besides AF, these were added to their personal CHAD2 Score, correlating with the
annual risk of stroke. The expected annual stroke rate without treatment was calculated
to be 5,3 % on the average (1,9 %-18,2 %). Two patients whose LAA was occluded suf-
fered from a stroke six month after implantation of the device. The annual stroke rate of
PLAATO™ patients was therefore calculated to be 2,9 % on the
average. In one case, there was no relation to the device or the implantation, in the other,
the relation is unknown.
Conclusions: As far as the interim follow up results show, transcatheter occlusion of the
LAA with the PLAATO™ device is not only a safe method, but seems to reduce the risk of
stroke in patients with AF.
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1006-55 In Vivo Macrophage Imaging of Acute Coronary 
Syndromes With Intracoronary Optical Coherence 
Tomography
Briain D. MacNeill, Ik Kyung Jang, Brett E. Bouma, Nicusor Iftimia, Masamichi Takano, 
Hiroshi Yabushita, Milen Shishkov, Guillermo J. Tearney, Massachusetts General 
Hospital, Boston, MA
Background: Atherosclerotic macrophage infiltration is a hallmark of coronary plaque
instability. Optical coherence tomography (OCT) is capable of imaging macrophages
within atherosclerotic plaque allowing quantitative and qualitative evaluation of coronary
inflammation.
Aim: To establish the pattern of macrophage infiltration in ST elevation myocardial infarc-
tion (STEMI) and other forms of acute coronary syndromes (ACS).
Methods & Results: We performed OCT at culprit sites and remote lesions in 38 patients
(19 STEMI, 19 ACS). A total of 95 lipid-rich plaques were analyzed. Macrophage density
was calculated as the normalized standard deviation (NSD) of the optical signal within
the superficial 50 microns of the fibrous cap. Macrophage heterogeneity was calculated
as the variance of the NSD. There was no significant difference in the macrophage den-
sity for STEMI and ACS groups (5.59 ± 1.70 %, 5.95 ± 1.88 %, P = NS). However, mac-
rophage heterogeneity was higher in the ACS group compared to the STEMI group (1.68
± 0.61 %, 2.1 ± 0.75 %, P = 0.007). Conclusion: Although the superficial macrophage
density is similar for both STEMI and ACS, the pattern of macrophage infiltration varies
significantly with a greater heterogeneity found in the ACS group.
Figure (A) OCT image of a lipid-rich plaque (LP) adjacent to a site of intimal disruption
(arrow). Scale bar = 500 µm; * represents guide wire shadow. (B) NSD image corre-
sponding to (A) demonstrating sites of high macrophage density (green to red).
1006-56 Virtual Histology of Intravascular Ultrasound Images: 
Feasibility and Clinical Correlations in Humans
Gary S. Mintz, Eugenia Nikolsky, William Wijns, Yoshio Kobayashi, Raimund Erbel, 
Roxana Mehran, Ramona Pop, Antonio Colombo, Patrick W. Serruys, Stephane G. 
Carlier, Alexandre Abizaid, D. Geoffrey Vince, Jeffrey W. Moses, Gregg W. Stone, Martin 
B. Leon, Cardiovascular Research Foundation, New York City, NY
Virtual histology (VH, Volcano Therapeutics) uses spectral analysis of backscattered
intravascular ultrasound (IVUS) to classify plaque elements as calcium, fibrotic, fibrofatty,
or lipid core. Algorithms have been derived and validated in vitro. We report the first in
vivo studies (68 native arteries in 50 pts). ECG-gated, motorized pullback IVUS images
are analyzed. External elastic membrane (EEM) and lumen borders are identified by
automatic edge detection; plaque&media is “separated” into its components. Results:
The length analyzed was 44±24mm (2.4±0.6 frames/mm). Total segment (lesion+refer-
ence) EEM volume was 539±317mm3, lumen was 256±159mm3, plaque&media was
283±176mm3, and %obstruction was 51±9%; calcium was 2±3%, fibrotic plaque
31±14%, fibrofatty plaque 14±16%, and lipid core 12±8% of total plaque&media volume.
When compared to pt characteristics, %total segment calcium was greater in stable
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angina vs acute coronary syndrome (2.1±2.8% vs 0.7±0.8%, p=0.0331). In diabetic pts,
%total segment fibrotic plaque (41±7% vs 29±14%, p=0.0286) and %lipid core (19±5%
vs 11±8%, p=0.0099) were larger vs non-diabetics. Importantly, %total segment lipid
core decreased with increasing HLD (r=0.44, p=0.0063), but there was no correlation
with LDL (Figure). Conclusions: VH affords real-time assessment of plaque histopathol-
ogy (not just grey scale images) that has been correlated to human necropsy specimens.
This information will reveal important correlations with clinical disease states. 
1006-57 Atherosclerotic Plaque Can Be Quantified Using 
Multifractal and Wavelet Decomposition Techniques
Liberty O. Yaneza, Robert J. Chilton, Edmund K. Kerut, Dimitrios Charalampidis, Dwight 
Chrisman, Michael S. Lujan, Carlos Leon Alviar, Thomas D. Giles, Robert A. O’Rourke, 
University of Texas Health Science Center, San Antonio, TX, State University Health 
Sciences Center, New Orleans, LA
Introduction:
Classification of plaque morphology into soft, fibrocalcific and calcific by intravascular
ultrasound (IVUS) is done by comparing plaque intensity to surrounding adventitia. How-
ever, this technique is subject to bias and to inherent limitation of IVUS machine.Texture
analysis is a form of tissue characterization based on the distribution of ultrasound ampli-
tude signals within a region-of-interest (ROI). Two methods, the wavelet decomposition
and multifractal techniques are currently being utilized to quantify image texture.
Methodology:
IVUS images performed from year 2000-2002 at the Cardiac Catheterization Laboratory
of South Texas Veterans Health Care Systems, San Antonio, Texas were analysed.
These images were exported into Desktop computer and analyzed after placing a 16 x
16 ROI box. Mean and standard deviation of pixel intensity values were generated.
Quantitation of ROI texture using 2 methods were performed by generation of multifractal
exponents, and normalized detail coefficients using wavelet decomposition method.
Results: 
Seventy three images were analysed. The overall intensity and energy generated by dif-
ferent plaque morphologies were significantly higher in calcific lesions as compared to
soft plaque. Furthermore, a significant association is also noted with different plaque
morphologies and texture analysis using both multifractal and wavelet decomposition
method. The values generated with texture analysis using multifractal exponents are
higher in calcific plaques as compared to soft lesions (0.539 +0.03 vs 0.504 +0.04, P
0.001).However, with wavelet decomposition method, the normalized detail coefficients
were significantly lower in calcific lesions (0.004 +0.01 vs 0.008 +0.00, P 0.006).
Conclusion:
A significant association was noted between plaque morphologies and texture analysis
using both wavelet decomposition and multifractal techniques. Using these techniques,
standard normalized values may be generated to classify plaques into truly calcific, fibro-
calcific and soft lesions. Additionally, these data may create values in further classifying
soft plaques into predominantly lipid, thrombus or necrotic degeneration.
1006-58 The Relation Between the Statin’s Effects on Coronary 
Plaque Composition and Plasma Low-Density 
Lipoprotein Cholesterol Level Evaluated by 
Intravascular Ultrasound Radiofrequency Signal 
Analysis
Masaki Yokoyama, Brian K. Courtney, Takashi Nakayama, Susumu Namikawa, Mizuo 
Nameki, Issei Komuro, Nobuyuki Komiyama, Chiba University Graduate School, Chiba, 
Japan, Stanford University Medical Center, Palo Alto, CA
Background: Many large trials reported that statins could reduce coronary events in pri-
mary and secondary prevention as well as plasma low-density lipoprotein cholesterol
(LDL) levels. Intravascular ultrasound radio-frequency signal (IVUS-RF) parameters such
as integrated backscatter (IB) have been shown to be useful in discriminating histological
components in human coronary plaques. We already reported that administration of sta-
tin for 6 months could clinically increase IB in human coronary plaques. In this study, we
sought to evaluate the relation between the plasma LDL levels and coronary plaque com-
position in a manner clinically detectable by IVUS-RF analysis.
Methods: Consecutive 20 patients undergoing percutaneous coronary intervention (PCI)
with plasma total cholesterol (TC) level between 180 and 230 mg / dl were investigated.
We searched for echo-lucent plaques in non-PCI-influenced coronary regions using a 40
MHz IVUS catheter after PCI and acquired IVUS-RF signals. The patients began to take
atorvastatin 10 mg / day after PCI procedure. At 6-month follow-up, plasma lipid levels
were measured in each patient and IVUS-RF signals were sampled at the same plaque
sites. Several regions of interest (ROIs) were placed on each plaque. IB was measured in
all ROIs blindly to the LDL data. Total of 148 ROIs were analyzed and %LDL change
(baseline LDL – follow-up LDL / baseline LDL x 100 (%)) was calculated in each patient.
Results: Plasma LDL level was significantly reduced from 133 ± 13 to 87 ± 29 mg / dl (p
< 0.0001) during the 6-month follow-up. IB was substantially increased from – 53.8 ± 4.5
to – 51.2 ± 4.9 dB (p < 0.0001). Increase of IB at the ROIs (n = 88) in patients with %LDL
change >= 40 % was significantly greater than at the ROIs (n = 60) in patients with %
LDL change < 40 % (3.79 ± 4.8 vs. 0.70 ± 3.6 dB; p< 0.0001), however, increase of IB
was not different between patients with LDL < 100 mg / dl and LDL >= 100 mg / dl at the
follow-up.
Conclusions: These results suggest that statin may alter acoustic properties of coronary
plaques and the effect of statin on plaque composition may not be related to the value of
LDL cholesterol at the end point but the amount of its reduction.
1006-59 Angioscopic Findings in Patients With Non-ST Elevation 
Acute Coronary Syndromes According to Troponin T 
Status
Kentaro Okamatsu, Kyoichi Mizuno, Shunta Sakai, Fumiyuki Ishibashi, Masamichi 
Takano, Nippon Medical School, Chiba Hokusoh Hospital, Chiba, Japan
Background It has been reported that troponin T could help improve the effectiveness of
such antithrombotic drugs as platelet glicoprotein IIb/IIIa antagonists in patients with non-
ST elevation acute coronary syndromes (NSTE-ACS). However, the mechanism remains
unclear. We therefore investigated the relationship between angioscopic lesion charac-
teristics and the troponin T release in NSTE-ACS. 
Methods and Results We studied 57 consecutive NSTE-ACS patients who underwent
angioscopy. Before catheterization, we obtained blood samples to determine troponin
positivity and the patients were classified as a troponin-positive and troponin-negative
group (diagnostic threshold; 0.1ng/ml). With angioscopy before angioplasty, we exam-
ined the presence of coronary thrombus, yellow plaque, and complex plaque. Twenty-two
patients were troponin-positive, and 35 patients were troponin-negative. No significant
differences were seen in the incidence of yellow plaque (77% vs. 83%), in the incidence
of complex plaque (64% vs. 68%) between the two groups. The incidence of coronary
thrombus detected with angioscopy in the troponin-positive group was significantly higher
than that in the troponin-negative group (86% vs. 34%; P=0.0001). Conclusions Using
angioscopy, the elevated troponin T levels in NSTE-ACS were confirmed to be strongly
associated with the presence of coronary thrombus, but not the atheroscrerotic change
of plaque itself. Our finding supports previous studies reported only the antithrombotic
drugs can neutralize the heightened risk of troponin-positive patients with NSTE-ACS.
1006-60 Coronary Arterial Wall Temperature Heterogenity in 
Patients With Acute Coronary Syndrome: An 
Intracoronary Thermography Study
Dariusz Dudek, Jacek Legutko, Lukasz Rzeszutko, Angela Richter, Marcin Wizimirski, 
Jacek S. Dubiel, Jagiellonian University, Krakow, Poland
Background: Increase of vessel wall temperature in patients with acute coronary syn-
drome (ACS) has been previously reported. The aim of this study was to assess the
safety and accuracy of intracoronary vessel wall temperature measurements in patients
with ACS using new catheter based, flow non-limiting thermography system.
Methods: We performed intracoronary thermography in 23 patients (pts) (mean age
54±10 years) with ACS (13 pts with acute myocardial infarction within 12 hours of chest
pain onset, 10 pts with unstable angina within 48 hours of the last chest pain) with TIMI 3
flow in the culprit artery before the procedure. We used 3.5-F thermography catheter
containing a self-expanding basket with 5 arms and a thermocouple on each arm mea-
suring vessel wall temperature, as well as a central thermocouple measuring blood tem-
perature, allowing detection of differences of 0.05ºC. Thermography was performed
before PCI of the culprit lesion. In all studied vessels we assessed blood temperature
(Tbl, ºC) and the maximum temperature difference between blood and any thermal cou-
ple (∆Tmax, ºC) during pullback (0.5mm/s).
Results: There were no device-related adverse effects or system failures. Mean Tbl was
36.7±0.7ºC and mean ∆Tmax was 0.093±0.032ºC. Temperature difference was higher in
the culprit segment in comparison to non culprit segment of the vessel (∆Tmax =
0.12±0.03 vs. 0.07±0.008, p<0,001). In one case, a focal 0.18ºC temperature peak was
recorded at the culprit lesion. In 6 pts thermography catheter stopped the flow during
thermal mapping when catheter was in a severely stenotic lesion. Tbl increased on aver-
age 0.2±0.07 with no flow at culprit segment, but it was paralleled by the increase in the
vessel wall temperature, so ∆Tmax remained unchanged.
Conclusions: Intracoronary thermography in patients with ACS was safe and able to
detect heterogeneous arterial wall temperature within the culprit vessel. Temperature
heterogeneity was higher in the culprit that in non culprit segment of the vessel.
1006-61 Coronary Lesion Temperature Measurement During 
Transient Blood Flow Occlusion Using a Novel Thermal 
Sensing System
Jorge A. Belardi, Fernando Cura, Lucio Padilla, Oscar Mendiz, Joseph Korotko, William 
O'Neill, Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina
Background: Temperature measurement of coronary arteries may provide lesion assess-
ment beyond conventional angiography and ultrasound imaging. It holds the potential to
be a predictor of future clinical events. However, studies have shown that blood flow
through an artery interferes with the ability to measure lesion temperature.
Methods: We performed the first in man application of a novel thermal sensing catheter
(Accumed Systems Inc, Ann Harbor, Mi) that temporarely occludes flow through the
artery to make temperature measurement in patients before undergoing elective percuta-
neous coronary intervention. On the distal portion of the catheter is an expandable braid
that is mounted on a pair of nested plastic tubes with three thermistors attached to the
exterior surface of the sleeve. The system takes a baseline reading of blood temperature
flowing through the artery and then surface temperature of the lesion while blood flow is
